Results 81 to 90 of about 8,165 (189)
Risks Associated with Drug Treatments for Kidney Stones [PDF]
, 2015 Introduction: Renal stones are one of the most painful medical conditions patients experience. For many they are also a recurrent problem. Fortunately, there are a number of drug therapies available to treat symptoms as well as prevent future stone ...
Borofsky, Michael S. +2 more
core +1 more source
Acta Crystallographica Section E, 2011 In the title compound {systematic name: [2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-1,3-thiazole-5-carboxylic acid (febuxostat) methanol monosolvate}, C16H16N2O3S·CH4O, the benzene and thiazole rings in the febuxostat molecule are twisted at 5.3 ...
Qi-Ying Jiang +4 more
doaj +1 more source
Особенности лечения подагры у пациентов пожилого возраста [PDF]
, 2012 Представлен обзор литературы по проблеме лечения подагры у пациентов пожилого ...
Андрианова, М. А. +3 more
core +2 more sources
Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study). [PDF]
, 2016 Determine the efficacy and safety of daily lesinurad (200 or 400 mg orally) added to allopurinol in patients with serum uric acid (sUA) above target in a 12-month, randomised, phase III trial.
Adler, S. +9 more
core +1 more source
Arthritis Research & Therapy, 2019 Background This study investigates the association between exposure to urate-lowering drugs (ULDs) and progression and recovery from chronic kidney disease (CKD). Methods We identified 5860 incident gout patients at Chang Gung Memorial Hospital from 2012
Ting-Ting Chung +9 more
doaj +1 more source
Relationship Between Characteristics of Medications and Drug-Induced Liver Disease Phenotype and Outcome [PDF]
, 2014 Background & Aims: It is not known if specific characteristics of medication are associated with type of drug-induced liver injury (DILI) or outcome.
Chalasani, Naga +8 more
core +1 more source
Diagnòstic i seguiment farmacoterapèutic de la hiperuricèmia i gota [PDF]
, 2017 Treballs d'Educació Farmacèutica als ciutadans. Unitat Docent d'Estades en Pràctiques Tutelades. Facultat de Farmàcia, Universitat de Barcelona. Curs: 2016-2017.
Barragán Muñoz, Àlex +4 more
core
DMW - Deutsche Medizinische Wochenschrift, 2011 K, Wittköpper, J, Emons, A, El-Armouche
openaire +5 more sources
Patients Prescribed Anakinra for Acute Gout Have Baseline Increased Burden of Hyperuricemia, Tophi, and Comorbidities, and Ultimate All-Cause Mortality. [PDF]
, 2019 Objective:The interleukin-1 (IL-1) receptor antagonist anakinra is an effective, off-label option in acute gout flares, when conventional therapy options are narrowed.
Pedersen, Brian +2 more
core